Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
57.52
+2.98 (5.46%)
Jan 21, 2025, 4:00 PM EST - Market closed
Rhythm Pharmaceuticals Employees
Rhythm Pharmaceuticals had 226 employees as of December 31, 2023. The number of employees increased by 49 or 27.68% compared to the previous year.
Employees
226
Change (1Y)
49
Growth (1Y)
27.68%
Revenue / Employee
$497,920
Profits / Employee
-$1,157,407
Market Cap
3.54B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
RYTM News
- 11 days ago - Rhythm Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2024 Net Product Revenues, Pipeline Advancements and Upcoming Milestones - GlobeNewsWire
- 4 weeks ago - Rhythm Pharmaceuticals' Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential - Benzinga
- 4 weeks ago - Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients as Young as 2 Years Old - GlobeNewsWire
- 7 weeks ago - Rhythm Pharmaceuticals Announces ▼ IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency to include Children as Young as 2 Years Old - GlobeNewsWire
- 2 months ago - Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide - GlobeNewsWire
- 2 months ago - Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & Endocrinology - GlobeNewsWire
- 2 months ago - Rhythm Pharmaceuticals Announces New Employment Inducement Grants - GlobeNewsWire
- 2 months ago - Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences - GlobeNewsWire